{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:38:35Z","timestamp":1754487515065,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Otolaryngological Department, Peking University Shenzhen Hospital","award":["NO. SZSM201612076"],"award-info":[{"award-number":["NO. SZSM201612076"]}]},{"name":"Scientific Research Project of Peking University Shenzhen Hospital in 2017","award":["LCYJ2017003"],"award-info":[{"award-number":["LCYJ2017003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Diabetes mellitus is associated with risk of sudden sensorineural hearing loss (SSNHL). Systemic and intratympanic corticosteroids are the two primary treatments for SSNHL in patients with diabetes mellitus. The benefit of intratympanic compared to systemic treatment is the reduced systemic steroid exposure and associated systemic adverse effects. Intratympanic corticosteroid administration may have potential benefits over standard systemic therapies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods\/design<\/jats:title>\n<jats:p>The proposed study is a prospective, randomized superiority trial. A total of 96 patients (48 in each group) will be randomized into the experimental or control group. Patients in the experimental group will receive four 1-mL doses of 40\u2009mg\/mL of methylprednisolone over a 1-week period, with a dose administered every 2\u2009days via tympanic membrane injection into the middle ear. The control group will be administered intravenous methylprednisolone (1\u2009mg\/kg\/day, maximal dose 60\u2009mg\/day) for 5\u2009days. The primary outcome for this study is the change in hearing threshold from the first audiogram to the 30-day follow-up audiogram. Secondary outcome measures will include pure-tone average (PTA) at 90-day follow up, visual analog tinnitus scale, visual analog vertigo scale, visual analog aural fullness scale, fasting blood glucose and 2-h postprandial blood glucose during treatment, and the change in glycosylated hemoglobin (HbA1C) levels. Vital signs and otological physical examination will be performed at each follow-up visit.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The efficacy and safety of intratympanic methylprednisolone compared to intravenous methylprednisolone will be investigated in patients with diabetes mellitus and SSNHL. This trial may provide strong evidence for the efficacy and safety of intratympanic corticosteroid treatment and important clinical information for the treatment of patients with diabetes mellitus and SSNHL.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>ChiCTR, ChiCTR1800015954. Registered on 2 May 2018, Retrospectively registered, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=25326\">http:\/\/www.chictr.org.cn\/showproj.aspx?proj=25326<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13063-020-4077-x","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T16:03:42Z","timestamp":1580745822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Weiqiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshuang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-8784","authenticated-orcid":false,"given":"Hongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"issue":"3 Suppl","key":"4077_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599812436449","volume":"146","author":"RJ Stachler","year":"2012","unstructured":"Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3 Suppl):S1\u201335.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"4077_CR2","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1097\/MAO.0000000000000222","volume":"34","author":"TH Alexander","year":"2013","unstructured":"Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol. 2013;34(9):1586\u20139.","journal-title":"Otol Neurotol"},{"issue":"6","key":"4077_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0025-7125(16)30384-4","volume":"75","author":"MJ Shikowitz","year":"1991","unstructured":"Shikowitz MJ. Sudden sensorineural hearing loss. Med Clin North Am. 1991;75(6):1239\u201350.","journal-title":"Med Clin North Am"},{"issue":"9","key":"4077_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/MAO.0b013e318271397a","volume":"33","author":"SW Lin","year":"2012","unstructured":"Lin SW, Lin YS, Weng SF, Chou CW. Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based cohort study. Otol Neurotol. 2012;33(9):1482\u20138.","journal-title":"Otol Neurotol"},{"issue":"11","key":"4077_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3950\/jibiinkoka.103.1227","volume":"103","author":"H Tomisawa","year":"2000","unstructured":"Tomisawa H. Diabetic changes in the stria vascularis in humans\u2013a study of PAS-stained temporal bone sections. Nihon Jibiinkoka Gakkai Kaiho. 2000;103(11):1227\u201337.","journal-title":"Nihon Jibiinkoka Gakkai Kaiho"},{"issue":"6","key":"4077_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archotol.1991.01870180071014","volume":"117","author":"RJ Triana","year":"1991","unstructured":"Triana RJ, Suits GW, Garrison S, Prazma J, Brechtelsbauer PB, Michaelis OE, et al. Inner ear damage secondary to diabetes mellitus. I. Changes in adolescent SHR\/N-cp rats. Arch Otolaryngol Head Neck Surg. 1991;117(6):635\u201340.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"4077_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5152\/iao.2018.4690","volume":"14","author":"WC Lan","year":"2018","unstructured":"Lan WC, Wang CY, Lin CD. Pentoxifylline versus steroid therapy for idiopathic sudden sensorineural hearing loss with diabetes. J Int Adv Otol. 2018;14(2):176\u201380.","journal-title":"J Int Adv Otol"},{"issue":"5","key":"4077_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.otohns.2009.06.084","volume":"141","author":"CS Han","year":"2009","unstructured":"Han CS, Park JR, Boo SH, Jo JM, Park KW, Lee WY, et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg. 2009;141(5):572\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"4077_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/01.mao.0000224092.79635.ee","volume":"27","author":"S Kakehata","year":"2006","unstructured":"Kakehata S, Sasaki A, Oji K, Futai K, Ota S, Makinae K, et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol. 2006;27(5):604\u20138.","journal-title":"Otol Neurotol"},{"issue":"10","key":"4077_CR10","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.2337\/diacare.27.10.2560-a","volume":"27","author":"SF Weng","year":"2004","unstructured":"Weng SF, Chen YS, Liu TC, Hsu CJ, Tseng FY. Prognostic factors of sudden sensorineural hearing loss in diabetic patients. Diabetes Care. 2004;27(10):2560\u20131.","journal-title":"Diabetes Care"},{"issue":"7 Pt 2","key":"4077_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","volume":"109","author":"LS Parnes","year":"1999","unstructured":"Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7 Pt 2):1\u201317.","journal-title":"Laryngoscope"},{"issue":"20","key":"4077_CR12","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1001\/jama.2011.679","volume":"305","author":"SD Rauch","year":"2011","unstructured":"Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305(20):2071\u20139.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"4077_CR13","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"American Diabetes A","year":"2010","unstructured":"American Diabetes A. Standards of medical care in diabetes\u20132010. Diabetes Care. 2010;33(Suppl 1):S11\u201361.","journal-title":"Diabetes Care"},{"issue":"8","key":"4077_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/lary.26394","volume":"127","author":"NG El Sabbagh","year":"2017","unstructured":"El Sabbagh NG, Sewitch MJ, Bezdjian A, Daniel SJ. Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope. 2017;127(8):1897\u2013908.","journal-title":"Laryngoscope"},{"issue":"6","key":"4077_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/archotol.133.6.582","volume":"133","author":"AE Conlin","year":"2007","unstructured":"Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133(6):582\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"12","key":"4077_CR16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archotol.1980.00790360050013","volume":"106","author":"WR Wilson","year":"1980","unstructured":"Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106(12):772\u20136.","journal-title":"Arch Otolaryngol"},{"issue":"10","key":"4077_CR17","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00405-017-4691-8","volume":"274","author":"G Ermutlu","year":"2017","unstructured":"Ermutlu G, Suslu N, Yilmaz T, Sarac S. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. Eur Arch Otorhinolaryngol. 2017;274(10):3585\u201391.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4077_CR18","doi-asserted-by":"publisher","unstructured":"Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2013;(7):CD003998. https:\/\/doi.org\/10.1002\/14651858.CD003998.pub3.","DOI":"10.1002\/14651858.CD003998.pub3"},{"issue":"1","key":"4077_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","volume":"43","author":"EB Geer","year":"2014","unstructured":"Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin N Am. 2014;43(1):75\u2013102.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"7","key":"4077_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/1753-0407.12631","volume":"10","author":"MAM Rogers","year":"2018","unstructured":"Rogers MAM, Lin P, Nallamothu BK, Kim C, Waljee AK. Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: risks and mitigating factors. J Diabetes. 2018;10(7):546\u201355.","journal-title":"J Diabetes"},{"issue":"1","key":"4077_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00129492-200101000-00005","volume":"22","author":"SS Chandrasekhar","year":"2001","unstructured":"Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22(1):18\u201323.","journal-title":"Otol Neurotol"},{"issue":"5","key":"4077_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MOO.0000000000000288","volume":"24","author":"CE Hobson","year":"2016","unstructured":"Hobson CE, Alexander TH, Harris JP. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone. Curr Opin Otolaryngol Head Neck Surg. 2016;24(5):407\u201312.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5","key":"4077_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.otohns.2009.08.009","volume":"141","author":"SM Hong","year":"2009","unstructured":"Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 2009;141(5):579\u201383.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"4077_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0194599812464475","volume":"148","author":"HJ Lim","year":"2013","unstructured":"Lim HJ, Kim YT, Choi SJ, Lee JB, Park HY, Park K, et al. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg. 2013;148(1):121\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"sup565","key":"4077_CR25","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1080\/00016489.2017.1297537","volume":"137","author":"R Kitoh","year":"2017","unstructured":"Kitoh R, Nishio SY, Ogawa K, Kanzaki S, Hato N, Sone M, et al. Nationwide epidemiological survey of idiopathic sudden sensorineural hearing loss in Japan. Acta Otolaryngol. 2017;137(sup565):S8\u2013S16.","journal-title":"Acta Otolaryngol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-4077-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T02:12:23Z","timestamp":1612231943000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4077-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4077"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4077-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial was approved by the Ethics Committees of Peking University Shenzhen Hospital in 26, October, 2017. The approval number is \u201c\u5317\u5927\u6df1\u533b\u4f26\u5ba1(\u7814)[2017] \u7b2c (009)\u53f7\u201d. Informed consent will be obtained from all participants who are enrolled to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}